Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-01-23 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document text is very short (264 characters) and is written in Danish. The text mentions 'Værdipapirhandelslovens paragraf 28a' (Securities Trading Act paragraph 28a) and details a transaction involving Novozymes shares (ISIN DK0060336014, NZYM B). This strongly indicates a mandatory disclosure of a transaction by an insider or related party, which corresponds to Director's Dealing (DIRS) or potentially a general regulatory filing (RNS). Given the specific nature of reporting share transactions by directors/executives, DIRS is the most precise fit, even though the text is an announcement snippet rather than the full report.
2012-01-23 Danish
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document text explicitly mentions 'reports the following transactions' related to ISIN DK0060336014 and Novozymes B shares, indicating a report of share transactions by an insider or related party. This directly aligns with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by directors and executives (insider trades). The document is very short and appears to be an excerpt from a regulatory filing detailing these transactions.
2012-01-23 English
Director's Dealing 2012
Director's Dealing Classification · 100% confidence The document text is extremely short (219 characters) and explicitly reports transactions under a specific section of the Danish Securities Trading Act, referencing ISIN and a stock symbol. This structure strongly suggests a mandatory disclosure of insider or related-party transactions, which aligns with the 'Director's Dealing' category (DIRS). Although it mentions 'Read the whole announcement,' implying a link to a fuller report, the content itself is the core transaction disclosure, making DIRS more specific than a general RPA or RNS. Given the context of reporting transactions by individuals associated with the company, DIRS is the most appropriate classification.
2012-01-23 English
Regulatory Filings 2012
Regulatory Filings Classification · 99% confidence The document text is very short (211 characters) and is written in Danish. It references the Danish Securities Trading Act ('Værdipapirhandelslovens paragraf 28a') and states that Novozymes must publish certain transactions related to its shares (ISIN DK0060336014, NZYM B). The phrase 'Læs hele meddelelsen' (Read the whole announcement) strongly suggests this is a brief notification about a required disclosure, rather than the full disclosure itself. This pattern aligns best with a general regulatory announcement or a specific insider transaction report. Since the content explicitly details transactions by insiders/directors ('transaktioner' related to company shares), the most specific fit among the provided codes is 'Director's Dealing' (DIRS). However, given the brevity and the nature of a general regulatory disclosure requirement being met, and lacking the specific details of the trade, it could also be a general Regulatory Filing (RNS). Comparing DIRS (insider trades) vs RNS (general regulatory filing), the content is specifically about director/insider transactions, making DIRS the primary candidate. If the text were longer and contained the actual trade details (price, volume), DIRS would be certain. As a short notice about required publication of transactions, DIRS is the most appropriate specific category, though RNS is a close fallback.
2012-01-23 Danish
Director's Dealing 2012
Director's Dealing
2012-01-20 Danish
Director's Dealing 2012
Director's Dealing
2012-01-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.